Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2017 08:00 ET | Source: Delcath Systems, Inc.

Delcath Issues Letter to Stockholders

NEW YORK, April 27, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq:DCTH) (the "Company"), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers,...
April 18, 2017 08:00 ET | Source: Delcath Systems, Inc.

Spire Southampton Hospital in UK Celebrating Over 100 CHEMOSAT Treatments

NEW YORK, April 18, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, commended Spire...
March 29, 2017 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces 2016 Financial Results

NEW YORK, March 29, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces...
March 27, 2017 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces Special Protocol Assessment Agreement With FDA for Pivotal Trial With Melphalan/HDS in Intrahepatic Cholangiocarcinoma

NEW YORK, March 27, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces it...
March 10, 2017 08:30 ET | Source: Delcath Systems, Inc.

Delcath Systems To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 13, 2017

NEW YORK, March 10, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, today announced...
February 22, 2017 08:00 ET | Source: Delcath Systems, Inc.

Published Review Shows Delcath Investigational PHP Doubles Overall Survival Over Other Targeted Liver Therapies

NEW YORK, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced today...
February 21, 2017 08:00 ET | Source: Delcath Systems, Inc.

Analysis From Two Institutions Shows Strong Tumor Response, Overall Survival Potential of Delcath Investigational PHP Therapy

NEW YORK, Feb. 21, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that a...
November 07, 2008 10:57 ET | Source: Delcath Systems, Inc.

Delcath Systems to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference

NEW YORK, NY--(Marketwire - November 7, 2008) - Delcath Systems (NASDAQ: DCTH), a leading developer of regional therapy for cancer, announced today that their President and CEO, Richard Taney, will...
October 21, 2008 08:49 ET | Source: Delcath Systems, Inc.

Delcath Systems' President and CEO Richard Taney to Present at Two Medical Technology Conferences

NEW YORK, NY--(Marketwire - October 21, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) a leading developer of regional therapy for liver cancer announced today that President and CEO Richard Taney will...
October 15, 2008 09:15 ET | Source: Delcath Systems

Delcath Systems Appoints Eamonn Hobbs to Board of Directors

NEW YORK, NY--(Marketwire - October 15, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) today announced the appointment of Mr. Eamonn Hobbs to Delcath's Board of Directors. Mr. Hobbs is President and...